What is the recommended epinephrine (adrenaline) dose for anaphylaxis in adults and children, including weight‑based intramuscular dosing and repeat dosing recommendations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Anaphylaxis

Administer intramuscular epinephrine 0.01 mg/kg (1:1000 concentration) immediately into the anterolateral thigh: maximum 0.5 mg for adults and 0.3 mg for children, repeated every 5-15 minutes as needed. 1, 2, 3

Adult Dosing

  • Standard dose: 0.3 to 0.5 mg of 1:1000 epinephrine (0.3-0.5 mL) intramuscularly into the anterolateral thigh 2, 3
  • Repeat dosing: Every 5-15 minutes based on clinical response 1, 2, 3
  • Approximately 6-19% of adults require a second dose 2
  • Use a needle at least 1/2 to 5/8 inch long to ensure intramuscular delivery 3

Pediatric Dosing

Weight-Based Dosing

  • Children <30 kg: 0.01 mg/kg (0.01 mL/kg of 1:1000 solution) up to maximum 0.3 mg per injection 1, 3
  • Children ≥30 kg: 0.3 to 0.5 mg (same as adult dosing) 3
  • Repeat every 5-10 minutes as clinically indicated 3

Autoinjector Dosing by Weight

  • 7.5-15 kg: 0.1 mg autoinjector (newly available formulation) 1, 4
  • 10-25 kg: 0.15 mg autoinjector 5
  • ≥25 kg: 0.3 mg autoinjector 5
  • For infants <7.5 kg, the 0.15 mg autoinjector is still preferable to ampule/syringe methods despite slight overdosing, as manual dosing carries 40-fold variation in accuracy and dangerous delays 6

Route and Site of Administration

The intramuscular route into the anterolateral thigh (vastus lateralis) is mandatory for first-line treatment. 2, 5

  • IM injection in the lateral thigh achieves peak plasma concentration at 8±2 minutes versus 34±14 minutes with subcutaneous injection 5
  • Inject at a 90-degree angle perpendicular to the skin to ensure muscle penetration 5
  • Can be administered through clothing if necessary—do not delay 5
  • Avoid the deltoid muscle, which provides inferior absorption compared to the thigh 5
  • Do not inject repeatedly at the same site due to risk of tissue necrosis from vasoconstriction 3

Refractory Anaphylaxis: IV Epinephrine

Reserve intravenous epinephrine exclusively for cardiac arrest or profound hypotension unresponsive to multiple IM doses and aggressive fluid resuscitation. 2, 6

IV Bolus Dosing

  • Adults: 0.1-0.5 mg (1-5 mL of 1:10,000 solution) given slowly over several minutes with continuous cardiac monitoring 2
  • Children: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution; maximum 0.3 mg) given slowly over several minutes 6

IV Infusion Protocol

  • Add 1 mg (1 mL of 1:1000) epinephrine to 1000 mL of 0.9% normal saline 1
  • Start at 2 μg/min (2 mL/min or 120 mL/h) 1, 2
  • Titrate up to maximum 10 μg/min (10 mL/min or 600 mL/h) based on blood pressure, heart rate, and oxygenation 1, 2
  • Alternative concentration: 1 mg in 250 mL D5W (4 μg/mL) at 1-4 μg/min 6

Special Populations and Considerations

No Absolute Contraindications

  • Epinephrine has no absolute contraindications in anaphylaxis, even in elderly patients with cardiac disease, hypertension, or other comorbidities 1, 2, 5
  • The benefits of epinephrine far outweigh risks of adverse effects (transient pallor, tremor, anxiety, palpitations) 2

Patients on Beta-Blockers

  • May be refractory to epinephrine 6
  • Consider IV glucagon 1-2 mg (20-30 μg/kg in children, maximum 1 mg) over 5 minutes for refractory symptoms 6

Infants and Small Children

  • For infants weighing >7.5 kg, the speed and precision of a 0.15 mg autoinjector outweighs theoretical overdosing concerns compared to error-prone manual dosing 1
  • Hold the child's leg firmly and limit movement during injection to prevent needle injury 3

Critical Pitfalls to Avoid

  • Never delay epinephrine while administering antihistamines or corticosteroids first—delay is associated with fatal outcomes 5, 6, 7
  • Never use subcutaneous route instead of intramuscular, which delays absorption by 4-fold 5
  • Never withhold epinephrine due to fear of adverse effects—mortality risk from untreated anaphylaxis far exceeds epinephrine risks 1, 2
  • Never use ampule/syringe/needle for home use due to 40-fold dosing variation and dangerous delays 6
  • Never administer IV epinephrine in non-arrest situations without continuous cardiac monitoring and appropriate expertise 6, 8
  • Do not confuse concentrations: IM uses 1:1000 (1 mg/mL); IV uses 1:10,000 (0.1 mg/mL) 3
  • Do not underdose by using pediatric autoinjectors in children ≥25 kg—switch to adult 0.3 mg dose at this threshold 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018

Guideline

Anaphylaxis Treatment with IM Adrenaline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

Safety of epinephrine for anaphylaxis in the emergency setting.

World journal of emergency medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.